Jeffrey B. Kindler - 28 Dec 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role: Director
Signature: /s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Issuer symbol: PGEN
Transactions as of: 28 Dec 2023
Net transactions value: -$136,327
Form type: 4
Filing time: 29 Dec 2023, 19:19:40 UTC
Previous filing: 14 Jun 2023
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGEN	Common Stock	Sale	$136,327	-96,686	-29%	$1.41	238,275	28 Dec 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership ("Parkview 2020"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023.

Content

On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership ("Parkview 2020"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023.